Korean disclosure
Samsung Biologics 207940Samsung Biologics signed a supply contract worth KRW 93.5 billion.
Supply ContractFiled
Unofficial English translation by ChickenStock; the Korean original prevails. Korean page · Original filing on DART ↗
Highlights
Structured dataSamsung Biologics signed a supply contract worth KRW 93.5 billion. The contract equals 2.1% of its recent revenue.
Written in code from the structured data of the filing. Reference information, not investment advice.
Key figures
- Contract amount
- KRW 93.5 billion
- Share of recent revenue
- 2.1%
Filing facts
- Filing type
- Supply Contract
- Report name
- Single Sales or Supply Contract (Voluntary)
- Filed
- Oct 2, 2026
- Receipt number
- 20261002800830